These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33538466)

  • 1. The Family Update: An Underappreciated Challenge in Treating Critically Ill Patients With COVID-19.
    Moran JV
    Acad Med; 2021 Aug; 96(8):1086-1087. PubMed ID: 33538466
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 Disease and Outcomes among Critically Ill Patients: The Case of Medical Nutritional Therapy.
    Karayiannis D; Kakavas S; Bouloubasi Z; Mastora Z
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35406029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Our insight about Mukhtar et al.'s outcome of non-invasive ventilation in COVID-19 critically ill patients.
    Karim HMR; Esquinas AM
    Anaesth Crit Care Pain Med; 2021 Feb; 40(1):100781. PubMed ID: 33197639
    [No Abstract]   [Full Text] [Related]  

  • 4. Family access to critically ill patients with COVID-19: a noble but demanding goal.
    Protti A; Porta V; Severgnini P; Monti G; Bottino N; Rondelli E; Dei Poli M; Stocchetti N;
    Minerva Anestesiol; 2021 Aug; 87(8):956-958. PubMed ID: 33688706
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological Subpopulations Within Critically Ill COVID-19 Patients.
    Wilson JK; Shankar-Hari M
    Chest; 2021 May; 159(5):1706-1708. PubMed ID: 33609517
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.
    Rao CM; Jena SK; Patnaik S; Singh N; Gupta S; Priyadarshini S; Pradhan S; Das S
    J Assoc Physicians India; 2021 May; 69(5):42-49. PubMed ID: 34189886
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
    Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
    J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging findings of critically ill patients with COVID-19 pneumonia: a case series.
    Woo SC; Yung KS; Wong T; Yu ELM; Li SK; Chan HF; Chan CH; Lee YC; Chan JMC; Leung WS
    Hong Kong Med J; 2020 Jun; 26(3):236-239. PubMed ID: 32362589
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of prolonged prone ventilation in critically ill COVID-19 patients: A short report.
    Garg SK; Garg P
    J Infect Public Health; 2022 Apr; 15(4):397-399. PubMed ID: 35305366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
    Al Sulaiman K; Aljuhani O; Al Dossari M; Alshahrani A; Alharbi A; Algarni R; Al Jeraisy M; Al Harbi S; Al Katheri A; Al Eidan F; Al Bekairy AM; Al Qahtani N; Al Muqrin M; Vishwakarma R; Al Ghamdi G
    Crit Care; 2021 Jun; 25(1):223. PubMed ID: 34193235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
    Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
    In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
    Yang X; Yu Y; Xu J; Shu H; Xia J; Liu H; Wu Y; Zhang L; Yu Z; Fang M; Yu T; Wang Y; Pan S; Zou X; Yuan S; Shang Y
    Lancet Respir Med; 2020 May; 8(5):475-481. PubMed ID: 32105632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study.
    Sadhu AR; Serrano IA; Xu J; Nisar T; Lucier J; Pandya AR; Patham B
    J Diabetes Sci Technol; 2020 Nov; 14(6):1065-1073. PubMed ID: 33063556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
    Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
    J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
    [No Abstract]   [Full Text] [Related]  

  • 15. Excess COVID-19 mortality among critically ill patients in Africa.
    Kirenga BJ; Byakika-Kibwika P
    Lancet; 2021 May; 397(10288):1860-1861. PubMed ID: 34022973
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-infectious and post-acute sequelae of critically ill adults with COVID-19.
    Ibrahim H; Athar S; Harhara T; Elhag SA; MElnour S; Sukkar HH; Kamour AM
    PLoS One; 2021; 16(6):e0252763. PubMed ID: 34138871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of critically ill patients with COVID-19.
    Carboni Bisso I; Huespe I; Lockhart C; Massó A; Gonzalez Anaya J; Hornos M; Famiglietti R; Di Grazia M; Coria P; San Román E; Las Heras M
    Medicina (B Aires); 2021; 81(4):527-535. PubMed ID: 34453793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of secondary infections in COVID-19 critically ill patients.
    Murgia F; Fiamma M; Serra S; Olla S; Garau MC; Cocco E; Lorefice L; Muntoni S; Paffi P; Porru S; Abis M; Finco G; Bellizzi S; Massidda O; Carta F; Atzori L
    J Infect; 2022 Jun; 84(6):e116-e117. PubMed ID: 35314266
    [No Abstract]   [Full Text] [Related]  

  • 19. mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland.
    Hilty MP; Keiser S; Wendel Garcia PD; Moser A; Schuepbach RA;
    Intensive Care Med; 2022 Mar; 48(3):362-365. PubMed ID: 35050384
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertriglyceridemia in Critically Ill Patients With SARS-CoV-2 Infection.
    El Nekidy WS; Shatnawei A; Abdelsalam MM; Hassan M; Dajani RZ; Salem N; St John TJL; Rahman N; Hamed F; Mallat J
    Ann Pharmacother; 2022 Jun; 56(6):637-644. PubMed ID: 34470517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.